OCT Explore the Opioid Crisis and Chronic Pain Pandemic in Pharmafocus Magazine

Pain waits for no one

In the October issue of Pharmafocus, John Lucas and Chloe Morris explore how cannabinoids could be the answer to chronic pain pandemic, if developed as licensed drug products. The opioid crisis is a manifestation of a silent pandemic where chronic pain patients are desperate for effective treatments and physicians are left with few options.

Previous
Previous

Oxford Cannabinoid Technologies Targets Chronic Pain Condition with Latest Formulation

Next
Next

Good shape, good budget and on track for Oxford Cannabinoid Technologies Holdings